Ultracentrifugation

Type: Keyphrase

Name: Ultracentrifugation

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Alfa Wassermann, Inc. - Product Pipeline Analysis, 2013 Update

SummaryAlfa Wassermann, Inc. (Alfa Wassermann) is a clinical device manufacturer. It designs and manufactures devices and equipment for clinical laboratories and diagnostic centers. The company’s products include medical diagnostic instruments and reagents ... [Published MarketResearch.com - May 17 2013]

Entities: Alfa Wassermann SpA, Clinical trials, Pipeline

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Carbon nanotubes reinforce particle characterisation

Beckman Coulter has released an application note detailing the hydrophobic nature of the carbon nanotubes.Related FilesSign in Register You need to be signed in to view the files below:‘Particle Characterisation’ seeks to explain the emerging impact carbon ... [Published Laboratorytalk - May 02 2013]

Entities: Carbon Nanotube, Beckman Coulter Inc, Ultracentrifugation, Zeta Potential

First reported Mar 27 2013 - Updated Mar 27 2013 - 1 reports

Many Cholesterol Readings Are Misleading

The standard formula used to calculate bad cholesterol is inadequate, researchers have found. And that is putting patients at a higher risk of heart disease.Researchers from Johns Hopkins examined the usefulness of a formula known as the Friedewald equation. ... [Published ThirdAge - Mar 27 2013]

Entities: Cholesterol, Seth Martin, Heart Disease, Ultracentrifugation

First reported Jan 23 2013 - Updated Jan 23 2013 - 1 reports

Beckman Coulter Inc

Interview: GPU-Accelerated Life Sciences at Beckman Coulter

Over at the Nvidia Developer Zone , Calisa Cole interviews Bob Zigon of Beckman Coulter , a company that develops, manufactures and markets products that simplify and automate complex biomedical testing. Zigon is working on a working on a prototype ... [Published insideHPC - Jan 23 2013]

Entities: Beckman Coulter Inc, Life Science, Ultracentrifugation, NVIDIA Corp

Quotes

"In contrast, assays of comparable sensitivity and specificity for detecting and/or quantifying Gram positive bacterial contaminants have been more difficult to develop. One assay for detecting Gram positive bacterial contamination, known as the In Vitro Pyrogen Test (IPT), is available from Charles River Laboratories (Wilmington, Mass.). The IPT assay is an in vitro alternative to the rabbit pyrogen test, and is an ELISA-based assay that uses fresh or cryoproserved human whole blood. When exposed to pyrogens, immune cells within the whole blood produce interleukin-1 .beta. that is detected in the ELISA assay. The IPT assay, however, does not selectively detect the presence of Gram positive bacteria, as it is activated by pyrogens present in Gram positive bacteria, Gram negative bacteria, yeasts and viruses."

Patent Issued for Methods for the Detection And/Or Quantific. . . [Published Equities.com - May 22 2013]

More Content

sort by: Date \| Relevance
Multicolor silicon-quantum-dot light-emitting d... [Published OE Magazine - 21 hours ago]
Patent Issued for Methods for the Detection And... [Published Equities.com - May 22 2013]
Production, Purification and Characterization o... [Published Elites TV - May 22 2013]
Alfa Wassermann, Inc. - Product Pipeline Analys... [Published MarketResearch.com - May 17 2013]
Patent Issued for Methods for Purification of A... [Published Equities.com - May 15 2013]
Carbon nanotubes reinforce particle characteris... [Published Laboratorytalk - May 02 2013]
ApoE Does Not Bind Aβ, Competes for Clearance [Published Alzheimer Research Forum - Apr 29 2013]
Many Cholesterol Readings Are Misleading [Published ThirdAge - Mar 27 2013]
New England Peptide Announces License Agreement [Published PRWeb - Mar 07 2013]
Interview: GPU-Accelerated Life Sciences at Bec... [Published insideHPC - Jan 23 2013]
Targeted gene delivery to dendritic cells [Published PharmCast - Oct 10 2012]